The Cell and Gene Therapy Catapult (CGT Catapult) last week published the ‘National Cell and Gene Therapy Vision for the UK’, a document outlining recommendations
In a recent feature for Pharmaceutical Market Europe, Director for Pathway Transformation at IQVIA, Ingrid Martin asks how healthcare practitioners can help achieve better patient outcomes through collaboration.
The Government has published draft terms of reference for the forthcoming public inquiry into the COVID-19 pandemic.
This rare disease day, Chamber commissioned a special episode of Innovating Healthcare to discuss the publication of the new Rare Disease Action Plan in England and speak to people impacted by rare conditions.
A new report, published by Policy@Manchester looks at pioneering research and treatment being conducted in Manchester and how the region’s care networks are serving as an example of international best practice.
IQVIA’s plans to support Integrated Care Systems with the delivery of the NHS Recovery Plan.
out how the Department of Health and Social Care and delivery partners will implement the UK Rare Diseases Framework in England has been published.
A white paper published last year by IQVIA, Alexion and AstraZeneca considers how the Innovative Medicines Fund can transition from the Cancer Drugs Fund and question how the fund can be effective in its goal of getting promising treatments to patients.
For Rare Disease Day, Head of Paediatrics at the University of Cambridge, Professor David Rowitch discusses recent research findings.
The Prime Minister set an ambitious target to make the UK a “life science superpower” and Curia’s NHS Life Sciences Commission will scope ways to
A Paralysed man with severed spine walks thanks to implant, as researchers have created human spinal cord implants in a world first.
In the third of a series of features, leading experts in the healthcare and life science sectors joined the Science Minister and the Mayor of Cambridgeshire and Peterborough at a question-time debate panel discussion in Cambridge.
Receive our latest insights, future journals as soon as they are published and get invited to our exclusive events and webinars.
We respect your privacy and will not share your email address with any third party. Your personal data will be collected and handled in accordance with our Privacy Policy.
Receive our latest insights and all future journals as soon as they are published and get invited to our exclusive events and webinars.
We respect your privacy and will not share your email address with any third party. Your personal data will be collected and handled in accordance with our Privacy Policy.
Receive our latest insights and all future journals as soon as they are published and get invited to our exclusive events and webinars.
We respect your privacy and will not share your email address with any third party. Your personal data will be collected and handled in accordance with our Privacy Policy.
Receive our latest insights as soon as they are published and get invited to our exclusive events and webinars.
We respect your privacy and will not share your email address with any third party. Your personal data will be collected and handled in accordance with our Privacy Policy.
